Internal Medicine, Endocrinology, Diabetes, & Metabolism · Ormond Beach, FL
NPI
1396705570
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
300 Clyde Morris Blvd Ste A
Ormond Beach, FL, 32174
Phone (386) 317-8620
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
348 services
Medicare patients, 2024
130
Average age 74
Drug cost, 2024
$1.0M
4,976 prescriptions
Company payments, 2025
$101
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gerald Miceli was code 99214 (office e&m - established), 154 times for 84 patients. In total Gerald Miceli billed 348 services in 15 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 154 | 84 | $86.80 | $13K |
| 95251 Test - Miscellaneous | Office | 62 | 31 | $24.55 | $1,522 |
| 99213 Office E&M - Established | Office | 45 | 38 | $53.62 | $2,413 |
By year: 2022 $26K for 369 services; 2023 $28K for 441 services; 2024 $21K for 348 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 27 | 13 | $8.24 | $223 |
Medicare prescription drug claims, 2024
In 2024, the drug Gerald Miceli prescribed most often to Medicare patients was Levothyroxine Sodium, with 613 prescriptions and refills. In total Gerald Miceli wrote 4,976 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 613 | 1,743 | 176 | $9,777 |
| Farxiga Dapagliflozin Propanediol | 328 | 449 | 55 | $181K |
| Rosuvastatin Calcium Generic | 225 | 619 | 67 | $9,453 |
| Bydureon Bcise Exenatide Microspheres | 216 | 280 | 40 | $160K |
| Metformin Hcl Generic | 195 | 574 | 68 | $4,120 |
| Ultra Thin Pen Needle, Diabetic | 165 | 362 | 62 | $2,896 |
| Novolog Flexpen Insulin Aspart | 162 | 332 | 51 | $25K |
| Atorvastatin Calcium Generic | 149 | 443 | 54 | $4,547 |
| Lisinopril Generic | 135 | 403 | 43 | $2,423 |
| Novolin 70-30 Flexpen Insulin Nph Hum/Reg Insulin Hm | 120 | 273 | 35 | $4,800 |
| Insulin Degludec Pen (U-200) Insulin Degludec | 117 | 255 | 29 | $26K |
| Metformin Hcl Er Metformin Hcl | 111 | 329 | 43 | $2,560 |
| Glimepiride Generic | 107 | 270 | 31 | $2,121 |
| Losartan Potassium Generic | 96 | 268 | 27 | $2,095 |
| Insulin Degludec Pen (U-100) Insulin Degludec | 87 | 170 | 25 | $11K |
Brand drugs: 2,137 claims; generic drugs: 2,344 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gerald Miceli $101 ($101 in general payments such as food, travel and fees) from 3 companies. The largest payer was Tandem Diabetes Care, Inc. with $57.62.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.